Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Healthcare Spending: Expenditure data by government, insurers, and out-of-pocket by patients.
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. mRNA Therapeutics Market Segmentation, by Application
7.1 Chapter Overview
7.2 Therapeutic
7.2.1 Therapeutic Market Trends Analysis (2020-2032)
7.2.2 Therapeutic Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Oncology
7.3.1 Oncology Market Trends Analysis (2020-2032)
7.3.2 Oncology Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Rare Genetic Diseases
7.4.1 Rare Genetic Diseases Market Trends Analysis (2020-2032)
7.4.2 Rare Genetic Diseases Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Respiratory Diseases
7.5.1 Respiratory Diseases Market Trends Analysis (2020-2032)
7.5.2 Respiratory Diseases Market Size Estimates and Forecasts to 2032 (USD Billion)
7.6 Others
7.3.1 Others Market Trends Analysis (2020-2032)
7.3.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
8. mRNA Therapeutics Market Segmentation, by Type
8.1 Chapter Overview
8.2 Prophylactic
8.2.1 Prophylactic Market Trends Analysis (2020-2032)
8.2.2 Prophylactic Market Size Estimates and Forecasts to 2032 (USD Million)
8.3 Therapeutic
8.3.1 Therapeutic Market Trends Analysis (2020-2032)
8.3.2 Therapeutic Market Size Estimates and Forecasts to 2032 (USD Million)
9. mRNA Therapeutics Market Segmentation, by End User
9.1 Chapter Overview
9.2 Hospitals & Clinics
9.2.1 Hospitals & Clinics Market Trends Analysis (2020-2032)
9.2.2 Hospitals & Clinics Market Size Estimates and Forecasts to 2032 (USD Million)
9.3 Research Organizations
9.3.1 Research Organizations Market Trends Analysis (2020-2032)
9.3.2 Research Organizations Market Size Estimates and Forecasts to 2032 (USD Million)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America mRNA Therapeutics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.2.3 North America mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.2.4 North America mRNA Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.2.5 North America mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.2.6 USA
10.2.6.1 USA mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.2.6.2 USA mRNA Therapeutics Market Estimates and Forecasts, by Type (2020-2032) (USD Million)
10.2.6.3 USA mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.2.7 Canada
10.2.7.1 Canada mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.2.7.2 Canada mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.2.7.3 Canada mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.2.8 Mexico
10.2.8.1 Mexico mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.2.8.2 Mexico mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.2.8.3 Mexico mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe mRNA Therapeutics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.3.1.3 Eastern Europe mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.4 Eastern Europe mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.3.1.5 Eastern Europe mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.3.1.6 Poland
10.3.1.6.1 Poland mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.6.2 Poland mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.3.1.6.3 Poland mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.3.1.7 Romania
10.3.1.7.1 Romania mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.7.2 Romania mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.3.1.7.3 Romania mRNA Therapeutics Market Estimates and Forecasts, by End Use(2020-2032) (USD Million)
10.3.1.8 Hungary
10.3.1.8.1 Hungary mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.8.2 Hungary mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.3.1.8.3 Hungary mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.3.1.9 turkey
10.3.1.9.1 Turkey mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.9.2 Turkey mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.3.1.9.3 Turkey mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.10.2 Rest of Eastern Europe mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.3.1.10.3 Rest of Eastern Europe mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe mRNA Therapeutics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.3.2.3 Western Europe mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.4 Western Europe mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.3.2.5 Western Europe mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.3.2.6 Germany
10.3.2.6.1 Germany mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.6.2 Germany mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.3.2.6.3 Germany mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.3.2.7 France
10.3.2.7.1 France mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.7.2 France mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.3.2.7.3 France mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.3.2.8 UK
10.3.2.8.1 UK mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.8.2 UK mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.3.2.8.3 UK mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.3.2.9 Italy
10.3.2.9.1 Italy mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.9.2 Italy mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.3.2.9.3 Italy mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.3.2.10 Spain
10.3.2.10.1 Spain mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.10.2 Spain mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.3.2.10.3 Spain mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.11.2 Netherlands mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.3.2.11.3 Netherlands mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.12.2 Switzerland mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.3.2.12.3 Switzerland mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.3.2.13 Austria
10.3.2.13.1 Austria mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.13.2 Austria mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.3.2.13.3 Austria mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.14.2 Rest of Western Europe mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.3.2.14.3 Rest of Western Europe mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific mRNA Therapeutics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.4.3 Asia Pacific mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.4 Asia Pacific mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.4.5 Asia Pacific mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.4.6 China
10.4.6.1 China mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.6.2 China mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.4.6.3 China mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.4.7 India
10.4.7.1 India mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.7.2 India mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.4.7.3 India mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.4.8 Japan
10.4.8.1 Japan mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.8.2 Japan mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.4.8.3 Japan mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.4.9 South Korea
10.4.9.1 South Korea mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.9.2 South Korea mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.4.9.3 South Korea mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.4.10 Vietnam
10.4.10.1 Vietnam mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.10.2 Vietnam mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.4.10.3 Vietnam mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.4.11 Singapore
10.4.11.1 Singapore mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.11.2 Singapore mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.4.11.3 Singapore mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.4.12 Australia
10.4.12.1 Australia mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.12.2 Australia mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.4.12.3 Australia mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.13.2 Rest of Asia Pacific mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.4.13.3 Rest of Asia Pacific mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East mRNA Therapeutics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.5.1.3 Middle East mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.4 Middle East mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.5.1.5 Middle East mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.5.1.6 UAE
10.5.1.6.1 UAE mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.6.2 UAE mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.5.1.6.3 UAE mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.5.1.7 Egypt
10.5.1.7.1 Egypt mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.7.2 Egypt mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.5.1.7.3 Egypt mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.8.2 Saudi Arabia mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.5.1.8.3 Saudi Arabia mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.5.1.9 Qatar
10.5.1.9.1 Qatar mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.9.2 Qatar mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.5.1.9.3 Qatar mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.10.2 Rest of Middle East mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.5.1.10.3 Rest of Middle East mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa mRNA Therapeutics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.5.2.3 Africa mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.2.4 Africa mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.5.2.5 Africa mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.5.2.6 South Africa
10.5.2.6.1 South Africa mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.2.6.2 South Africa mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.5.2.6.3 South Africa mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.2.7.2 Nigeria mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.5.2.7.3 Nigeria mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.2.8.2 Rest of Africa mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.5.2.8.3 Rest of Africa mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America mRNA Therapeutics Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.6.3 Latin America mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.4 Latin America mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.6.5 Latin America mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.6.6 Brazil
10.6.6.1 Brazil mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.6.2 Brazil mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.6.6.3 Brazil mRNA Therapeutics Market Estimates and Forecasts, by End Use(2020-2032) (USD Million)
10.6.7 Argentina
10.6.7.1 Argentina mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.7.2 Argentina mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.6.7.3 Argentina mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.6.8 Colombia
10.6.8.1 Colombia mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.8.2 Colombia mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.6.8.3 Colombia mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America mRNA Therapeutics Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.9.2 Rest of Latin America mRNA Therapeutics Market Estimates and Forecasts, by Type(2020-2032) (USD Million)
10.6.9.3 Rest of Latin America mRNA Therapeutics Market Estimates and Forecasts, by End User(2020-2032) (USD Million)
11. Company Profiles
11.1 Moderna Inc.
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 BioNTech SE
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 CureVac N.V.
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 Arcturus Therapeutics
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 Argos Therapeutics Inc.
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 Sanofi
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 GSK Plc.
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 Sangamo therapeutics
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 AstraZeneca
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 Pfizer Inc.
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusio
